scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1023509840 |
P356 | DOI | 10.1038/377748A0 |
P3181 | OpenCitations bibliographic resource ID | 3836263 |
P698 | PubMed publication ID | 7477267 |
P2093 | author name string | B L Hogan | |
S Okuyama | |||
T Ichiki | |||
A Fogo | |||
I Ichikawa | |||
T Inagami | |||
F Niimura | |||
C Shiota | |||
Y Imagawa | |||
P A Labosky | |||
P2860 | cites work | Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice | Q24303396 |
Human type 2 angiotensin II receptor gene: cloned, mapped to the X chromosome, and its mRNA is expressed in the human lung | Q28117226 | ||
Expression of AT2 receptors in the developing rat fetus | Q34198676 | ||
Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice | Q35186061 | ||
Subtype 2 of angiotensin II receptors controls pressure-natriuresis in rats | Q35554353 | ||
Angiotensin II AT2 receptor stimulation increases cerebrovascular resistance during hemorrhagic hypotension in rats | Q36728062 | ||
Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. | Q37584984 | ||
The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells | Q38299038 | ||
Molecular actions of angiotensin | Q40127382 | ||
Levels of angiotensin and molecular biology of the tissue renin angiotensin systems | Q40872210 | ||
Angiotensin II receptor subtypes: characterization, signalling mechanisms, and possible physiological implications. | Q40903553 | ||
Expression, genomic organization, and transcription of the mouse angiotensin II type 2 receptor gene | Q48074029 | ||
Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor | Q48225244 | ||
Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor | Q48225253 | ||
A G protein is involved in the angiotensin AT2 receptor inhibition of the T-type calcium current in non-differentiated NG108-15 cells. | Q55481180 | ||
Generation and analysis of interleukin-4 deficient mice | Q57339987 | ||
Effects of angiotensin subtype 1 and subtype 2 receptor antagonists in normotensive versus hypertensive rats | Q67764474 | ||
Gene targeting in embryonic stem cells | Q72583953 | ||
P433 | issue | 6551 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Angiotensin II receptor, type 2 | Q21983453 |
P304 | page(s) | 748-50 | |
P577 | publication date | 1995-10-26 | |
P1433 | published in | Nature | Q180445 |
P1476 | title | Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor | |
P478 | volume | 377 |
Q34159332 | 20-Hydroxyeicosatetraenoic acid synthesis is increased in human neutrophils and platelets by angiotensin II and endothelin-1. |
Q28297569 | 50 years of hurdles and hope in anxiolytic drug discovery |
Q47323334 | A Cre-loxP solution for defining the brain renin-angiotensin system. Focus on "Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain". |
Q48667990 | A new transgenic rat model overexpressing the angiotensin II type 2 receptor provides evidence for inhibition of cell proliferation in the outer adrenal cortex |
Q24634320 | A novel angiotensin II type 2 receptor signaling pathway: possible role in cardiac hypertrophy |
Q37269304 | A peripherally administered, centrally acting angiotensin II AT2 antagonist selectively increases brain AT1 receptors and decreases brain tyrosine hydroxylase transcription, pituitary vasopressin and ACTH. |
Q89223942 | AGTR2 absence or antagonism prevents cystic fibrosis pulmonary manifestations |
Q30434317 | ANG II type 2 receptor regulates smooth muscle growth and force generation in late fetal mouse development |
Q42669920 | AT(2) but not AT(1) receptor antagonism abolishes angiotensin II increase of the acquisition of conditioned avoidance responses in rats. |
Q42014112 | AT(2) receptor-dependent vasodilation is mediated by activation of vascular kinin generation under flow conditions |
Q43800030 | AT(2) receptor-mediated vasodilation in the heart: effect of myocardial infarction |
Q44490998 | AT1 and AT2 receptors in human glomerular endothelial cells at different passages |
Q44555026 | AT1 antagonism by eprosartan lowers heart rate variability and baroreflex gain |
Q48104246 | AT2 R deficiency mediated podocyte loss via activation of ectopic hedgehog interacting protein (Hhip) gene expression |
Q30275852 | AT2 Receptors: Potential Therapeutic Targets for Hypertension |
Q26829592 | AT2 receptor activities and pathophysiological implications |
Q37821128 | AT2 receptor signaling and sympathetic regulation |
Q35047332 | AT2 receptor-mediated vasodilatation is unmasked by AT1 receptor blockade in conscious SHR. |
Q41819451 | AT2 receptor-mediated vasodilation in the mouse heart depends on AT1A receptor activation |
Q38208962 | AT2 receptors targeting cardiac protection post-myocardial infarction |
Q37274124 | AT2 receptors: functional relevance in cardiovascular disease. |
Q52684443 | AT2R (Angiotensin II Type 2 Receptor)-Mediated Regulation of NCC (Na-Cl Cotransporter) and Renal K Excretion Depends on the K Channel, Kir4.1. |
Q34126751 | Acute hyperglycemia rapidly stimulates VEGF mRNA translation in the kidney. Role of angiotensin type 2 receptor (AT2). |
Q37598488 | Adapter proteins and promoter regulation of the angiotensin AT2 receptor--implications for cardiac pathophysiology |
Q77718867 | Adrenal angiotensin II type 1 and type 2 receptors in Cushing's and Conn's syndromes |
Q83467008 | Aldosterone/NaCl-induced renal and cardiac fibrosis is modulated by TGF-β responsiveness of T cells |
Q33970724 | Analysis of organ physiology in transgenic mice |
Q54017975 | Analysis of responses to angiotensin II in the mouse. |
Q34558074 | Angiotensin AT(2) receptor contributes towards gender bias in weight gain |
Q73689200 | Angiotensin AT(2) receptors mediate vasodepressor response to footshock in rats. Role of kinins, nitric oxide and prostaglandins |
Q34558572 | Angiotensin AT2 receptor ligands: do they have potential as future treatments for neurological disease? |
Q35045801 | Angiotensin AT2 receptors: cardiovascular hope or hype? |
Q48106483 | Angiotensin II AT2 Receptors Contribute to Regulate the Sympathoadrenal and Hormonal Reaction to Stress Stimuli. |
Q53298621 | Angiotensin II AT2 receptor oligomers mediate G-protein dysfunction in an animal model of Alzheimer disease. |
Q33727770 | Angiotensin II AT2 receptor regulates ureteric bud morphogenesis |
Q52543165 | Angiotensin II Receptor Physiology Using Gene Targeting. |
Q30423556 | Angiotensin II acts through the angiotensin 1a receptor to upregulate pendrin |
Q28577645 | Angiotensin II and NGF differentially influence microtubule proteins in PC12W cells: role of the AT2 receptor |
Q34064179 | Angiotensin II and calcium channels |
Q36649671 | Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade |
Q26765849 | Angiotensin II during Experimentally Simulated Central Hypovolemia |
Q43797608 | Angiotensin II in cardiac pressure-overload hypertrophy in fetal sheep |
Q48311566 | Angiotensin II in central nervous system physiology |
Q45049892 | Angiotensin II increases differentiation of dopaminergic neurons from mesencephalic precursors via angiotensin type 2 receptors |
Q78207338 | Angiotensin II is a growth factor in the peri-implantation rat embryo |
Q74265524 | Angiotensin II is bound to both receptors AT1 and AT2, parallel to the transmembrane domains and in an extended form |
Q44692644 | Angiotensin II mediates Tyr-dephosphorylation in rat fetal kidney membranes |
Q54076543 | Angiotensin II receptor (type 1 and 2) expression peaks when placental growth is maximal in sheep. |
Q38167346 | Angiotensin II receptor antagonists in acute coronary syndromes |
Q34622302 | Angiotensin II receptor antagonists role in arterial hypertension |
Q41623699 | Angiotensin II receptors in endothelial cells |
Q48292966 | Angiotensin II receptors in the human brain |
Q28346704 | Angiotensin II reduces infarct size and has no effect on post-ischaemic contractile dysfunction in isolated rat hearts |
Q57630567 | Angiotensin II signal transduction pathways |
Q42155832 | Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium |
Q77687808 | Angiotensin II stimulates both aldosterone secretion and DNA synthesis via type 1 but not type 2 receptors in bovine adrenocortical cells |
Q44904447 | Angiotensin II stimulates nitric oxide production in pulmonary artery endothelium via the type 2 receptor |
Q46103013 | Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes. |
Q37986143 | Angiotensin II type 2 receptor agonists: where should they be applied? |
Q37344123 | Angiotensin II type 2 receptor blockade increases bone mass |
Q51825386 | Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice. |
Q52954250 | Angiotensin II type 2 receptor gene polymorphism and cardiovascular phenotypes: the GLAECO and GLAOLD studies. |
Q40851849 | Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation |
Q34990858 | Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism |
Q74023758 | Angiotensin II type 2 receptor stimulation of neuronal delayed-rectifier potassium current involves phospholipase A2 and arachidonic acid |
Q24338401 | Angiotensin II type 2 receptor-mediated vasodilation in human coronary microarteries |
Q36081206 | Angiotensin II type 2 receptor-mediated vasodilation. Focus on bradykinin, NO and endothelium-derived hyperpolarizing factor(s). |
Q37340136 | Angiotensin II type 2 receptors have a major somatodendritic distribution in vasopressin-containing neurons in the mouse hypothalamic paraventricular nucleus |
Q42987208 | Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase |
Q38895396 | Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2. |
Q41701250 | Angiotensin II type-I receptor antagonists in the treatment of heart failure |
Q35971305 | Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease? |
Q38359804 | Angiotensin II-induced contraction is attenuated by nitric oxide in afferent arterioles from the nonclipped kidney in 2K1C. |
Q77943856 | Angiotensin II: a reproductive hormone too? |
Q44618349 | Angiotensin Subtype 1 Receptor (AT1) Blockade Improves Vasorelaxation in Heart Failure by Up-Regulation of Endothelial Nitric-Oxide Synthase via Activation of the AT2Receptor |
Q34268762 | Angiotensin and its AT2 receptor: new insights into an old system |
Q37250548 | Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels |
Q73579468 | Angiotensin receptor subtypes in the uterine artery during ovine pregnancy |
Q30585823 | Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury |
Q37395730 | Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria |
Q44249678 | Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR. |
Q28284938 | Angiotensin receptors in the nervous system |
Q33687045 | Angiotensin receptors: molecular biology and signalling |
Q38275879 | Angiotensin type 1 and type 2 receptors during ontogeny: cardiovascular and renal effects |
Q51590953 | Angiotensin type 2 receptor null mice express reduced levels of renal angiotensin II type 2 receptor/angiotensin (1-7)/Mas receptor and exhibit greater high-fat diet-induced kidney injury. |
Q35236405 | Angiotensin type 2 receptors: blood pressure regulation and end organ damage |
Q24680069 | Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas |
Q36267261 | Angiotensin-(1-7) protects against the development of aneurysmal subarachnoid hemorrhage in mice |
Q28566875 | Angiotensin-II type 1 receptor and NOX2 mediate TCF/LEF and CREB dependent WISP1 induction and cardiomyocyte hypertrophy |
Q35927004 | Angiotensin-converting enzyme and male fertility |
Q37402767 | Angiotensin-converting enzyme-induced activation of local angiotensin signaling is required for ascending aortic aneurysms in fibulin-4-deficient mice. |
Q36520564 | Angiotensinogen Exerts Effects Independent of Angiotensin II. |
Q28507336 | Anti-apoptotic action of angiotensin fragments to neuronal cells from angiotensinogen knock-out mice |
Q48271554 | Anxiety-like behavior in mice lacking the angiotensin II type-2 receptor |
Q57085383 | Are Retinal Microvascular Phenotypes Associated With the 1675G/A Polymorphism in the Angiotensin II Type-2 Receptor Gene? |
Q59282923 | Association between angiotensin-converting enzyme gene polymorphism and competitive anxiety in Tunisian athlete |
Q48947565 | Autoradiographic localization of angiotensin II receptors in developing rat cerebellum and brainstem |
Q40860075 | Behavior in mice with targeted disruption of single genes |
Q24303396 | Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice |
Q37853834 | Blood pressure and renal hemodynamic effects of angiotensin fragments |
Q73515538 | Brain AT(2) receptor mediate vasodepressor response to footshocks: role of kinins and nitric oxide |
Q37127331 | Brain renin angiotensin in disease |
Q82768839 | C3123A polymorphism of the angiotensin II type 2 receptor gene and salt sensitivity in healthy Japanese men |
Q35188971 | Candidate Agtr2 influenced genes and pathways identified by expression profiling in the developing brain of Agtr2(-/y) mice |
Q28505671 | Cardiac-specific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects |
Q47316917 | Cardioprotective effect of thyroid hormone is mediated by AT2 receptor and involves nitric oxide production via Akt activation in mice. |
Q48835664 | Cardiovascular ATIP (Angiotensin receptor type 2 interacting protein) expression in mouse development |
Q37377636 | Cellular localization of AT1 receptor mRNA and protein in normal placenta and its reduced expression in intrauterine growth restriction. Angiotensin II stimulates the release of vasorelaxants |
Q45154803 | Central angiotensin II AT1 receptors mediate fetal swallowing and pressor responses in the near-term ovine fetus |
Q44851212 | Changing dietary sodium alters the chronic cardiovascular effects of losartan in rats |
Q40853041 | Characterization and distribution of angiotensin II receptor subtypes in the mouse brain. |
Q47962393 | Chemical lesion of the inferior olive reduces [125I]sarcosine1-angiotensin II binding to AT2 receptors in the cerebellar cortex of young rats |
Q37360830 | Chimeric mice carrying 'regional' targeted deletion of the angiotensin type 1A receptor gene. Evidence against the role for local angiotensin in the in vivo feedback regulation of renin synthesis in juxtaglomerular cells |
Q34065655 | Classical Renin-Angiotensin system in kidney physiology |
Q34809342 | Commercially available angiotensin II At₂ receptor antibodies are nonspecific. |
Q35130093 | Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on blood pressure and the kidney |
Q35125556 | Comparison of the transcriptomes of mouse skin derived precursors (SKPs) and SKP-derived fibroblasts (SFBs) by RNA-Seq |
Q37365115 | Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes |
Q43253857 | Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential |
Q64076698 | Connexin37-Dependent Mechanisms Selectively Contribute to Modulate Angiotensin II -Mediated Hypertension |
Q92710285 | Counter-regulatory renin-angiotensin system in cardiovascular disease |
Q36441725 | Creation and characterization of a renin knockout rat. |
Q36404466 | Cross-talk of the renin-angiotensin and kallikrein-kinin systems |
Q89394623 | Crystal structure of the human angiotensin II type 2 receptor bound to an angiotensin II analog |
Q34162513 | Cyclic AMP-independent involvement of Rap1/B-Raf in the angiotensin II AT2 receptor signaling pathway in NG108-15 cells |
Q77525024 | Deferential roles of angiotensin receptor subtypes in adrenocortical function in mice |
Q24310775 | Deficiency of intrarenal angiotensin II type 2 receptor impairs paired homeo box-2 and N-myc expression during nephrogenesis |
Q42421685 | Dependence of renal microvessel density on angiotensin II: only in the fetus? |
Q40061741 | Development of an AT2-deficient proximal tubule cell line for transport studies |
Q33641872 | Development of fetal brain renin-angiotensin system and hypertension programmed in fetal origins |
Q34557839 | Developmental changes in AT1 and AT2 receptor-protein expression in rats |
Q45239069 | Developmental expression patterns for angiotensin receptors in mouse skin and brain |
Q51927508 | Developmental renin expression in mice with a defective renin-angiotensin system. |
Q38079544 | Different cross-talk sites between the renin-angiotensin and the kallikrein-kinin systems |
Q48655552 | Differential action of AGCF2 upon cell type-dependent expression of human angiotensinogen gene |
Q28533596 | Differential mechanisms of activation of the Ang peptide receptors AT1, AT2, and MAS: using in silico techniques to differentiate the three receptors |
Q44542218 | Differential vasoconstrictions induced by angiotensin II: role of AT1 and AT2 receptors in isolated C57BL/6J mouse blood vessels. |
Q88538682 | Dimerization of AT2 and Mas Receptors in Control of Blood Pressure |
Q34543485 | Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers. |
Q48522887 | Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain |
Q47617969 | Dose-dependent inhibitory effects of angiotensin II on visual responses of the rat superior colliculus: AT1 and AT2 receptor contributions |
Q35782663 | Early expression of all the components of the renin-angiotensin-system in human development |
Q32032127 | Early streptozotocin-diabetes mellitus downregulates rat kidney AT2 receptors |
Q44390736 | Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto rats |
Q43967973 | Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors |
Q73098656 | Effect of cortisol on fetal ovine vascular angiotensin II receptors and contractility |
Q74450181 | Effects of ACTH on adrenal angiotensin II receptor subtype expression in vivo |
Q43631831 | Effects of TCV-116 on expression of NOS and adrenomedullin in failing heart of Dahl salt-sensitive rats |
Q42452224 | Effects of angiotensin II on nitric oxide generation in growing and resting rat aortic endothelial cells |
Q57597959 | Effects of angiotensin II receptor antagonists on anxiety and some oxidative stress markers in rat |
Q37365932 | Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors |
Q48269962 | Effects of targeted disruption of the mouse angiotensin II type 2 receptor gene on stress-induced hyperthermia |
Q42993543 | Efficient transcription of the human angiotensin II type 2 receptor gene requires intronic sequence elements |
Q35218190 | Electronic sculpting of ligand-GPCR subtype selectivity: the case of angiotensin II. |
Q44838500 | Elevated blood pressure in normotensive rats produced by 'knockdown' of the angiotensin type 2 receptor |
Q33894083 | Elevated testosterone levels during rat pregnancy cause hypersensitivity to angiotensin II and attenuation of endothelium-dependent vasodilation in uterine arteries |
Q43263750 | Endothelial AT(2)-receptors: chicken or egg? |
Q35673075 | Erythropoiesis and Blood Pressure Are Regulated via AT1 Receptor by Distinctive Pathways |
Q44174214 | Estrogen upregulates renal angiotensin II AT(2) receptors |
Q40431943 | Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload |
Q35850581 | Exploring type I angiotensin (AT1) receptor functions through gene targeting. |
Q48226506 | Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown |
Q24563508 | Expression of the AT2 receptor developmentally programs extracellular signal-regulated kinase activity and influences fetal vascular growth |
Q38340269 | G protein-coupled receptors: functional and mechanistic insights through altered gene expression |
Q35839992 | Gain-of-function mutant of angiotensin II receptor, type 1A, causes hypertension and cardiovascular fibrosis in mice |
Q40861559 | Gene disruption in mice: models of development and disease |
Q35176920 | Gene-targeting studies of the renin-angiotensin system: mechanisms of hypertension and cardiovascular disease |
Q48813717 | Genetic alteration of alpha 2C-adrenoceptor expression in mice: influence on locomotor, hypothermic, and neurochemical effects of dexmedetomidine, a subtype-nonselective alpha 2-adrenoceptor agonist |
Q48861743 | Genetic deletion of angiotensin AT2 receptor leads to increased cell numbers in different brain structures of mice |
Q79105221 | Genetic disorders of human congenital anomalies of the kidney and urinary tract (CAKUT) |
Q37871869 | Genetically modified mouse models used for studying the role of the AT2 receptor in cardiac hypertrophy and heart failure |
Q37801858 | Glycation in diabetic nephropathy |
Q36208883 | High Na intake increases renal angiotensin II levels and reduces expression of the ACE2-AT(2)R-MasR axis in obese Zucker rats |
Q41953838 | High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats |
Q38069825 | How does angiotensin AT(2) receptor activation help neuronal differentiation and improve neuronal pathological situations? |
Q34520314 | Hypertension and angiotensin II hypersensitivity in aminopeptidase A-deficient mice. |
Q44249518 | Identification of the region of AT2 receptor needed for inhibition of the AT1 receptor-mediated inositol 1,4,5-triphosphate generation |
Q44642393 | Identification of two AGTR2 mutations in male patients with non-syndromic mental retardation. |
Q37416298 | Impact of AT2-receptor stimulation on vascular biology, kidney function, and blood pressure |
Q51892892 | Impaired spatial memory and altered dendritic spine morphology in angiotensin II type 2 receptor-deficient mice. |
Q44935105 | Importance of the angiotensin type 1 receptor in angiotensin II-induced bronchoconstriction and bronchial hyperresponsiveness in the guinea pig. |
Q45294803 | Importance of the renin-angiotensin system in the regulation of arterial blood pressure in conscious mice and rats |
Q73031645 | In vitro pharmacological characterization of a new selective angiotensin AT1 receptor antagonist, UR-7280 |
Q78050736 | In-vivo electrophysiological study in mice with chronic anterior myocardial infarction |
Q43766131 | Increased AT(1) receptors in adrenal gland of AT(2) receptor gene-disrupted mice |
Q37461915 | Increased angiotensin II AT1 receptor mRNA and binding in spleen and lung of AT2 receptor gene disrupted mice |
Q42210462 | Increased expression of angiotensin II type 2 receptors in the solitary-vagal complex blunts renovascular hypertension. |
Q30304142 | Increased renal vasodilator prostanoids prevent hypertension in mice lacking the angiotensin subtype-2 receptor |
Q57630554 | Insights derived from ACE knockout mice |
Q35850538 | Insights into angiotensin II receptor function through AT2 receptor knockout mice |
Q33987660 | Insights into the functions of type 1 (AT1) angiotensin II receptors provided by gene targeting |
Q48061654 | Insulin and insulin-like growth factors induce expression of angiotensin type-2 receptor in vascular-smooth-muscle cells |
Q91693385 | Interaction between Angiotensin Type 1, Type 2, and Mas Receptors to Regulate Adult Neurogenesis in the Brain Ventricular-Subventricular Zone |
Q78229164 | Interactions between AT1 and AT2 receptors in uterine arteries from pregnant ewes |
Q36241932 | International Union of Basic and Clinical Pharmacology. XCIX. Angiotensin Receptors: Interpreters of Pathophysiological Angiotensinergic Stimuli [corrected]. |
Q42645323 | Intraindividual blood pressure responses to angiotensin-converting enzyme inhibition and angiotensin receptor blockade. |
Q52937062 | Intronic ANG II type 2 receptor gene polymorphism 1675 G/A modulates receptor protein expression but not mRNA splicing. |
Q34052052 | Ischemic cardiomyopathy and the cellular renin-angiotensin system |
Q38061004 | Key developments in renin-angiotensin-aldosterone system inhibition. |
Q36460819 | Knockout of Angiotensin AT2 receptors accelerates healing but impairs quality |
Q34140879 | Knockout of renin-angiotensin system genes: effects on vascular development |
Q35912250 | Lifestyle intervention might easily improve blood pressure in hypertensive men with the C genotype of angiotensin II type 2 receptor gene |
Q34731369 | Ligand-independent signals from angiotensin II type 2 receptor induce apoptosis |
Q37308105 | Local stress, not systemic factors, regulate gene expression of the cardiac renin-angiotensin system in vivo: a comprehensive study of all its components in the dog. |
Q48705203 | Localization of angiotensin-converting enzyme, angiotensin II, angiotensin II receptor subtypes, and vasopressin in the mouse hypothalamus |
Q46047739 | Maternal adaptation in pregnant hypertensive rats: improvement of vascular and inflammatory variables and oxidative damage in the kidney. |
Q48493960 | Maternal nutrient restriction in sheep: hypertension and decreased nephron number in offspring at 9 months of age. |
Q34420641 | Measuring normal and pathological anxiety-like behaviour in mice: a review. |
Q30306044 | Mechanism of action of angiotensin-receptor blocking agents |
Q90191397 | Mice lacking angiotensin type 2 receptor exhibit a sex-specific attenuation of insulin sensitivity |
Q52170561 | Modulation of angiotensin II receptor expression during development and regression of hypoxic pulmonary hypertension. |
Q48672854 | Modulation of angiotensin II type 2 receptor mRNA in rat hypothalamus and brainstem neuronal cultures by growth factors. |
Q41084357 | Molecular biology of angiotensin receptors and their role in human cardiovascular disease |
Q36062244 | Molecular evidence of tissue renin-angiotensin systems: a focus on the brain |
Q34140872 | Mouse models of blood pressure regulation and hypertension |
Q37828217 | Mouse systems for studying the genetics of hypertension and related disorders |
Q28592947 | Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes |
Q48564719 | Mutation of a conserved fifth transmembrane domain lysine residue (Lys215) attenuates ligand binding in the angiotensin II type 2 receptor |
Q47734837 | Neuronal ion channel signalling pathways: modulation by angiotensin II. |
Q35079395 | New approaches to genetic manipulation of mice: tissue-specific expression of ACE. |
Q36996244 | New insights into the importance of aminopeptidase A in hypertension |
Q34028215 | New insights into the renin-angiotensin system and hypertensive renal disease |
Q46938289 | Nicotine modulates the renin-angiotensin system of cultured neurons and glial cells from cardiovascular brain areas of Wistar Kyoto and spontaneously hypertensive rats. |
Q52525698 | Normotensive blood pressure in mice with a disrupted renin Ren-1d gene. |
Q92304592 | OLIG2 Drives Abnormal Neurodevelopmental Phenotypes in Human iPSC-Based Organoid and Chimeric Mouse Models of Down Syndrome |
Q52184810 | Ontogeny and regulation of cardiac angiotensin types 1 and 2 receptors during fetal life in sheep. |
Q60274922 | Ontogeny of angiotensin II receptors, types 1 and 2, in ovine mesonephros and metanephros |
Q36296584 | Ontogeny of angiotensin type 2 and type 1 receptor expression in mice |
Q52099641 | Ontogeny of congenital anomalies of the kidney and urinary tract, CAKUT |
Q42571400 | Opportunities and limitations of genetic analysis of hypertensive rat strains |
Q49053455 | Opposite regulation of brain angiotensin type 1 and type 2 receptors in cold-induced hypertension |
Q34289976 | Origin, differentiation and regulation of fetal and adult Leydig cells |
Q31115399 | PD123319 augments angiotensin II-induced abdominal aortic aneurysms through an AT2 receptor-independent mechanism |
Q50510999 | PLS3 Deletions Lead to Severe Spinal Osteoporosis and Disturbed Bone Matrix Mineralization. |
Q42544169 | Participation of AT1 and AT2 receptor subtypes in the tonic inhibitory modulation of baroreceptor reflex response by endogenous angiotensins at the nucleus tractus solitarii in the rat. |
Q43562117 | Perinatal dietary NaCl level: effect on angiotensin-induced thermal and dipsogenic responses in adult rats |
Q30581028 | Pharmacology of eprosartan, an angiotensin II receptor antagonist: exploring hypotheses from clinical data |
Q28279771 | Physiology of kidney renin |
Q28379250 | Possible role of P-450 metabolite of arachidonic acid in vasodilator mechanism of angiotensin II type 2 receptor in the isolated microperfused rabbit afferent arteriole |
Q36812416 | Postprandial fatty acid uptake and adipocyte remodeling in angiotensin type 2 receptor-deficient mice fed a high-fat/high-fructose diet |
Q42503774 | Potentiation of the antihypertensive action of losartan by peripheral overexpression of the ANG II type 2 receptor. |
Q33650699 | Practical considerations of the pharmacology of angiotensin receptor blockers |
Q35841439 | Prenatal programming of angiotensin II type 2 receptor expression in the rat. |
Q77493413 | Presence of angiotensin II and expression of angiotensin II type-2 receptor in human fallopian tube |
Q41008506 | Pressor response to angiotensin II is enhanced in aged mice and associated with inflammation, vasoconstriction and oxidative stress |
Q34256543 | Promyelocytic leukemia zinc finger protein activates GATA4 transcription and mediates cardiac hypertrophic signaling from angiotensin II receptor 2. |
Q77104362 | Prostanoids, but not nitric oxide, counterregulate angiotensin II mediated vasoconstriction in vivo |
Q39294782 | Protective Angiotensin Type 2 Receptors in the Brain and Hypertension |
Q41820888 | Protective role of angiotensin II subtype 2 receptor in blood pressure increase in obese Zucker rats |
Q37100243 | Protective role of angiotensin II type 2 receptor signaling in a mouse model of pancreatic fibrosis |
Q27023787 | Rational drug design and synthesis of molecules targeting the angiotensin II type 1 and type 2 receptors |
Q34260674 | Recent advances involving the renin-angiotensin system |
Q38230104 | Recent insights and therapeutic perspectives of angiotensin-(1-9) in the cardiovascular system. |
Q37050391 | Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor. |
Q33593068 | Reduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II. |
Q35170122 | Regression of left ventricular hypertrophy is a key goal of hypertension management |
Q35127628 | Renal cortical cyclooxygenase 2 expression is differentially regulated by angiotensin II AT(1) and AT(2) receptors |
Q33858669 | Renal physiology of the mouse |
Q35782695 | Renin angiotensin system in development of mice and men |
Q34555338 | Renin enhancer is critical for control of renin gene expression and cardiovascular function. |
Q37269647 | Renin-angiotensin system revisited |
Q33658583 | Renin-angiotensin systems and reproduction |
Q35656144 | Reporter mouse strain provides a novel look at angiotensin type-2 receptor distribution in the central nervous system |
Q39091986 | Review: AT1-receptors in the central nervous system |
Q39091996 | Review: Gene targeting studies of angiotensin II type 1 (AT1) receptors |
Q39091992 | Review: Lessons on renal function from transgenic mice lacking different angiotensin II receptors |
Q37274546 | Role of ACE/AT2R complex in the control of mesenteric resistance artery contraction induced by ACE/AT1R complex activation in response to Ang I |
Q51432835 | Role of AT(1) receptors and autonomic nervous system in mediating acute pressor responses to ANG II in anesthetized mice. |
Q33883065 | Role of angiotensin AT1, and AT2 receptors in cardiac hypertrophy and disease |
Q36522928 | Role of angiotensin AT2 receptors and nitric oxide in the cardiopulmonary baroreflex control of renal sympathetic nerve activity in rats |
Q37225312 | Role of angiotensin II AT1 receptor activation in cardiovascular diseases |
Q37284634 | Role of mitogen-activated protein kinase in cardiac hypertrophy and heart failure |
Q28081615 | Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control |
Q63951732 | Role of the Angiotensin Type 2 Receptor Gene in Congenital Anomalies of the Kidney and Urinary Tract, CAKUT, of Mice and Men |
Q34117891 | Role of the angiotensin receptor in the development of the mammalian kidney and urinary tract |
Q43708511 | Role of the renin-angiotensin system during alterations of sodium intake in conscious mice |
Q26821934 | Roles of renal proximal tubule transport in acid/base balance and blood pressure regulation |
Q47962829 | Sciatic nerve transection evokes lasting up-regulation of angiotensin AT2 and AT1 receptor mRNA in adult rat dorsal root ganglia and sciatic nerves |
Q43625220 | Selective down-regulation of AT2 receptors in uterine arteries from pregnant ewes given 24-h intravenous infusions of angiotensin II. |
Q51117577 | Sex- and age-related differences in the chronic pressure-natriuresis relationship: role of the angiotensin type 2 receptor. |
Q33826656 | Signal transduction from the angiotensin II AT2 receptor |
Q73836268 | Single vaginal ectopic ureter and renal hypoplasia associated with urogenital sinus and abdominal muscular hypoplasia-a novel subtype of prune-belly syndrome in a female child? |
Q33330952 | Specific single chain variable fragment (ScFv) antibodies to angiotensin II AT(2) receptor: evaluation of the angiotensin II receptor expression in normal and tumor-bearing mouse lung |
Q40237075 | Strategy for the development of a matched set of transport-competent, angiotensin receptor-deficient proximal tubule cell lines |
Q36335687 | Structural basis for selectivity and diversity in angiotensin II receptors |
Q26765070 | Structure and functions of angiotensinogen |
Q30304009 | Sustained hypersensitivity to angiotensin II and its mechanism in mice lacking the subtype-2 (AT2) angiotensin receptor |
Q42989490 | Sustained phospholipase D activation in response to angiotensin II but not carbachol in bovine adrenal glomerulosa cells |
Q33680652 | The AT2 receptor: fact, fancy and fantasy |
Q36520049 | The Angiotensin II Type 2 Receptor in Brain Functions: An Update |
Q37150747 | The Frail Renin-Angiotensin System |
Q33962025 | The acute vascular effects of frusemide in heart failure |
Q34086986 | The angiotensin II AT2 receptor is an AT1 receptor antagonist. |
Q74428985 | The angiotensin II binding site on Mycoplasma hyorhynis is structurally distinct from mammalian AT1 and AT2 receptors |
Q30413945 | The angiotensin II type 2 receptor and the kidney |
Q37622575 | The angiotensin II type 2 receptor in cardiovascular disease |
Q37622583 | The angiotensin II type 2 receptor in the brain |
Q40559527 | The brain renin-angiotensin system plays a crucial role in regulating body weight in diet-induced obesity in rats |
Q34019802 | The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function |
Q40853213 | The interaction of nitric oxide, bradykinin, and the angiotensin II type 2 receptor: lessons learned from transgenic mice |
Q37526343 | The link between stress disorders and autonomic dysfunction in muscular dystrophy |
Q84805490 | The midgestational maternal blood pressure decline is absent in mice lacking expression of the angiotensin II AT2 receptor |
Q35202929 | The neurobiology and control of anxious states |
Q37622572 | The past, present and future of angiotensin II type 2 receptor stimulation |
Q37988002 | The regenerative potential of angiotensin AT2 receptor in cardiac repair. |
Q33217815 | The renin-angiotensin system: current data |
Q35105871 | The role of ACE2 in cardiovascular physiology |
Q37830311 | The role of G protein-coupled receptors in the pathology of Alzheimer's disease |
Q33838726 | The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis |
Q41386967 | The role of angiotensin receptors in cardiovascular diseases |
Q35028529 | The subtype 2 of angiotensin II receptors and pressure-natriuresis in adult rat kidneys |
Q39376362 | The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases. |
Q35677285 | Transgenesis and gene targeting in the mouse; tools for studying genetic determinants of hypertension |
Q34028513 | Transgenic and knockout mice to study the renin-angiotensin system and other interacting vasoactive pathways |
Q33799227 | Transgenic and knockout models in renin-angiotensin system |
Q52981348 | Transgenic animal models for the functional analysis of vasoactive peptides. |
Q35850586 | Transgenic mice for studies of the renin-angiotensin system in hypertension. |
Q34101139 | Transgenic mouse models of angiotensin receptor subtype function in the cardiovascular system |
Q38196317 | Unwrapping the origins and roles of the renal endothelium. |
Q44650642 | Up-Regulation of Angiotensin II Type 2 Receptor in Rat Thoracic Aorta by Pressure-Overload |
Q28077454 | Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease |
Q28580814 | Upregulation of AT2 receptor and iNOS impairs angiotensin II-induced contraction without endothelium influence in young normotensive diabetic rats |
Q37097104 | Vascular angiotensin AT2 receptors in hypertension and ageing |
Q34028504 | What can knockout mice contribute to an understanding of hypertension? |
Q41138757 | Will angiotensin II receptor antagonists be renoprotective in humans? |
Q56270643 | X-linked mental retardation |
Search more.